Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1

Journal of Acquired Immune Deficiency Syndromes

Volumn 23, Issue 2, 2000, Pages 138-144

  Bürgisser, Philippe ^a   Vernazza, Pietro ^b   Flepp, Markus ^c   Böni, Jürg ^d   Tomasik, Zuzana ^d   Hummel, Urs ^d   Pantaleo, Giuseppe ^a   Schüpbach, Jörg ^e  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e BH 18 ^*

Author keywords

Amplicor; HIV 1 subtypes; NucliSens; p24 antigen; PERT assay; Quantiplex; Viral load

Indexed keywords

VIRUS RNA;

ACCURACY; ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RNA ANALYSIS; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS LOAD;

EID: 12944250984     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200002010-00005     Document Type: Article

References (33)

1. Workshop Report from the European Commission (DG XII, INCO-DC) and the Joint United Nations Programme on HIV/ AIDS. HIV-1 subtypes: implications for epidemiology, pathogenicity, vaccines and diagnostics. AIDS 1997;11:UNAIDS17-36.
2. Dunne AL, Crowe SM. Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma. AIDS 1997;11:126-7.
3. Michael NL, Herman SA, Kwok S, et al. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. J Clin Microbiol 1999;37:2557-63.
4. Alaeus A, Lilja E, Herman S, Spadoro J, Wang J, Albert J. Assay of plasma samples representing different HIV-1 genetic subtypes: an evaluation of new versions of the Amplicor HIV-1 monitor assay. AIDS Res Hum Retroviruses 1999;15:889-94.
5. Coste J, Montes B, Reynes J, et al. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J Med Virol 1996;50:293-302.
6. Parekh B, Phillips S, Granade TC, Baggs J, Hu DJ, Respess R. Impact of HIV type 1 subtype variation on viral RNA quantitation. AIDS Res Hum Retroviruses 1999;15:133-42.
7. Gobbers E, Fransen K, Oosterlaken T, et al. Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes. J Virol Methods 1997;66:293-301.
8. Kern D, Collins M, Fultz T, et al. An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1996;34: 3196-3202.
9. Oelrichs RB, Dyer WB, Downie JC, Harvey K, Sullivan JS, Workman C. Inaccurate HIV-1 viral load quantification by three major commercially available methods. AIDS 1999;13:727-8.
10. Triques K, Coste J, Perret JL, et al. Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1. J Clin Microbiol 1999;37:110-16.
11. Segondy M, Ly TD, Lapeyre M, Montes B. Evaluation of the Nuclisens HIV-1 QT assay for quantitation of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol 1998;36:3372-4.
12. Schockmel GA, Yerly S, Perrin L. Detection of low HIV-1 RNA levels in plasma. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:179-83.
13. Böni J, Pyra H, Schüpbach J. Sensitive detection and quantification of particle-associated reverse transcriptase in plasma of HIV-1-infected individuals by the product-enhanced reverse transcriptase (PERT) assay. J Med Virol 1996;49:23-8.
14. Pyra H, Boni J, Schüpbach J. Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc Natl Acad Sci USA 1994;91:1544-48.
15. Nadal D, Boni J, Kind C, et al. Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. J Infect Dis 1999;180:1089-95.
16. Delwart EL, Shpaer EG, Louwagie J, et al. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 1993;262:1257-61.
17. Boni J, Pyra H, Gebhardt M, et al. High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. JAIDS J Acquir Immune Defic Syndr 1999;22:174-9.
18. Weissmahr RN, Schüpbach J, Boni J. Reverse transcriptase activity in chicken embryo fibroblast culture supernatants is associated with particles containing endogenous avian retrovirus EAV-0 RNA. J Virol 1997;71:3005-12.
19. Highbarger HC, Alvord WG, Jiang MK, et al. Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor Monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples. J Clin Microbiol 1999;37:3612-4.
20. Carr JK, Salminen MO, Koch C, et al. Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol 1996;70:5935-43.
21. Nkengasong JN, Kalou M, Maurice C, et al. Comparison of NucliSens and Amplicor monitor assays for quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma of persons with HIV-1 subtype A infection in Abidjan, Cote d'Ivoire. J Clin Microbiol 1998;36:2495-8.
22. Vandamme AM, Schmit JC, Van Dooren S, et al. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:127-39.
23. Brambilla D, Leung S, Lew J, et al. Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons. J Clin Microbiol 1998;36:311-4.
24. Nolte FS, Boysza J, Thurmond C, Clark WS, Lennox JL. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1998;36: 716-20.
25. Segondy M, Izopet J, Pellegrin I, et al. Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapy. J Clin Microbiol 1998; 36:3392-5.
26. Damond F, Apetrei C, Descamps D, Brun-Vézinet F, Simon F. HIV-1 subtypes and plasma RNA quantification. AIDS 1999;13: 286-7.
27. Cohen J. The daunting challenge of keeping HIV suppressed. Science 1997;277:32-3.
28. Le Grice SFJ, Mills J, Mous J. Active site mutagenesis of the AIDS virus protease and its alleviation by trans complementation. EMBO J 1988;7:2547-53.
29. Kaplan AH, Krogstad P, Kempf DJ, Norbeck DW, Swanstrom R. Human immunodeficiency virus type 1 virions composed of unprocessed Gag and Gag-Pol precursors are capable of reverse transcribing viral genomic RNA. Antimicrob Agents Chemother 1994; 38:2929-33.
30. Garcia Lerma JG, Yamamoto S, Gomez-Cano M, et al. Measurement of human immunodeficiency virus type 1 plasma virus load based on reverse transcriptase (RT) activity: evidence of variabilities in levels of virion-associated RT. J Infect Dis 1998;177: 1221-9.
31. Piatak M, Jr., Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-54.
32. Böni J, Opravil M, Tomasik Z, et al. Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS 1997;11F47-52.
33. Corrigan GE, Al-Khalili L, Malmsten A, et al. Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 subtype B viruses with a heterogeneous group of divergent strains. AIDS Res Hum Retroviruses 1998;14:347-52.